! -- End SE Verifications --> <! -- Pinterest Verification --> <! -- End Pinterest Verification -->
Region: China, United States
Project Timeline: 2022.02 – Present
Keywords: Closed-loop Talent Management, Data Privacy and Security
Solution Components: aTalentⓇ Talent Management Platform
Baoyuan Biomedical Technology (Hangzhou) Co., Ltd. (hereinafter referred to as AnHeart) was established in November 2018. It is headquartered in Hangzhou, Zhejiang Province, China, and has offices in Beijing, Shanghai and New York. AnHeart focuses on the development of innovative medicines that can significantly improve human health and improve the quality of life, especially the development of unmet clinical needs.
As a world-class biomedical technology enterprise, AnHeart was founded by a senior team with rich experience in global clinical development and registration declaration, 30% of its employees holding a PhD degree. At the beginning of its establishment, AnHeart adopted the research and development model of both China and the US, who was committed to developing new accurate oncology therapies to benefit the lcancer patients in China and around the world.
Being in the biomedical industry with high data security and compliance requirements, the AnHeart HR team has been looking for a highly adaptive digital management platform and solution to help them solve the problems regarding heavy daily work and data privacy security caused by their rapid business growth and cross-border management.
The core management team of aTalent comes from the world’s leading tech companies and consulting firms, with more than 10 years of HR management experience. aTalentⓇ Talent Management Platform was built locally in China but designed globally. Compared with world’s top HCM software vendors, aTalent has a better understanding of the local management methods and modes of thinking in China, in addition to its world-class product design concepts and strong platform architecture, as well as the thorough understanding of the global trend of HR management. aTalent has its products made closed to China’s local customers’ habits while ensuring that the products also suit well for global and diversified management.
aTalent has rich experience in global project delivery, especially in the biomedical industry with high data security and compliance requirements. aTalent has great knowledge of the data security compliance laws and regulations of many countries and regions around the world, especially mainland China, including Pharmaceutical Production Quality Management Code (GMP), U.S. Food and Drug Administration (FDA) 21 CFR Part 11, Mainland China Personal Information Protection Law (PIPL), etc., and help clients achieve global data transfer in a secure and comprehensive way.
Biomedicine is a cutting-edge industry, in which the talents normally reflect the company strength, therefore, AnHeart attaches great importance to its internal talent management. Faced with continuous innovation in science and technology, the “talent anxiety” in the biomedical industry is becoming more and more obvious.
As an industry-leading enterprise, AnHeart stays up-to-date with the modes of thinking and methods of talent management and it is committed to bringing excellent user experience to its internal talents through a high-quality modern management platform.
aTalent is committed to making everyone the best at work, which coincides with the core idea of AnHeart’s talent management and lays a solid foundation for the smooth cooperation between the two sides in the future.
Since the launch of the project, the work efficiency of HR has been greatly improved, and the cross-border management between their China and the US teams has become more agile and efficient.
New Account Activation
aTalent talent management platform breaks the information barriers of the Sino-US management team through our strong technical support and effectively improves the daily work efficiency of the AnHeart HR team so that more energy can be devoted to talent management.
In the next phase of the project, aTalent will bring a comprehensive optimization to AnHeart in the field of talent management. aTalentⓇ performance management will be introduced in the near future, and AnHeart is expected to create a more comprehensive high-end internal talent management system through the new aTalentⓇ Talent Marketplace module which will help them with the internal core talent optimization.
Baoyuan Biomedical Technology (Hangzhou) Co., Ltd. (hereinafter referred to as AnHeart) was established in November 2018. It is headquartered in Hangzhou, Zhejiang Province, China, and has offices in Beijing, Shanghai, and New York. AnHeart focuses on the development of innovative medicine that can significantly improve human health and improve quality of life.
In May 2019, AnHeart successfully completed the A round of $15 million financing and plans to establish and strengthen clinical innovative product pipelines through cooperation with large and medium-sized biopharmaceutical companies. At present, the company mainly develops tumor drugs in the later stage of clinical practice. At the same time, it is also developing and introducing products with a clear mechanism of action and supported by certain early clinical or preclinical data, exploring the rapid registration and listing of R&D pathways to provide more therapeutic drugs to meet clinical needs for patients in China and around the world.